✦ LIBER ✦

Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern italy

✍ Scribed by G. F. Elia; G. Magnani; S. Iacono; Silvia Marchelli; F. Ficcadori; Loredana Belli; Sandra Pincolini; A. Formentini; Rita Lecchini; G. Bernuzzi

Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 732 KB
Volume: 19
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01645359

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of antibody to hepatitis C v

Development of antibody to hepatitis C virus (HCV) in acute and chronic non-A, non-B post-transfusion hepatitis

✍ G. Pastore; L. Monno; M. Milella; T. Santantonio; M. G. Rumi; M. Colombo; A. Gia 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 375 KB

The antibody to hepatitis C virus (anti-HCV) was measured by an immunoassay in 507 serum samples from 94 patients with acute and chronic post-transfusion non-A, non-B hepatitis (NANB) and in 436 healthy blood donors. Anti-HCV was found in 70.8 of patients with acute hepatitis, in 78.2 with chronic h

Significance of antibody to hepatitis C

Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: Relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis

✍ Eiji Tanaka; Dr. Kendo Kiyosawa; Takeshi Sodeyama; Yoshiyuki Nakano; Kaname Yosh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

In a retrospective study, antibody to hepatitis C virus (anti-HCV antibody) was measured in 80 patients with acute viral hepatitis (type A, 18; type B, 21; type non-A,non-B, 41). Anti-HCV antibody was found in 12 of 20 patients (60%) with non-A,non-B post-transfusion hepatitis (NANB-PTH) and in 9 of

Etiological investigation of acute post-

Etiological investigation of acute post-transfusion non-A, non-B hepatitis in China

✍ Kang-Xian Luo; Zhi-Sen Liang; Shou-Chang Yang; Rong Zhou; Qing-Hua Meng; You-Wu 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

The etiology of acute post-transfusion hepatitis (PTH) non-A, non-B (NANB) in China was investigated with the combination of advanced techniques, including a second generation of enzyme immunoassay for detection of the antibodies to hepatitis C virus (anti-HCV), a reverse transcription and nested po

Interrelationship of blood transfusion,

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

✍ Kendo Kiyosawa; Takeshi Sodeyama; Eiji Tanaka; Yukio Gibo; Kaname Yoshizawa; Yos 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

To clarify the relationship between hepatitis C virus infection and the development of hepatocellular carcinoma as sequelae of non-A, non-B posttransfusion hepatitis, 231 patients with chronic non-A, non-B hepatitis (96 with chronic hepatitis, 81 with cirrhosis and 64 with hepatocellular carcinoma)

Contribution of hepatitis C virus to non

Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan

✍ Makoto Yoshiba; Kazuhiko Dehara; Kazuaki Inoue; Hiroaki Okamoto; Makoto Mayumi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 669 KB

To assess the contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan, we compared 10 mqjor clinical features among 7 patients with type B fulminant hepatitis (type B group), 13 patients with non-A, non-B fulminant hepatitis with evidence of hepatitis C virus infection (type C

Seroepidemiology of hepatitis E virus in

Seroepidemiology of hepatitis E virus in patients with non-A, non-B, non-C hepatitis in Hungary

✍ Annika Haagsman; Gábor Reuter; Erwin Duizer; Gyuláné Nagy; Tineke Herremans; Mar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Abstract Many cases of acute hepatitis remain undiagnosed and the hepatitis E virus (HEV) is emerging in industrialized countries. The aim of this study was to assess the role HEV as causative agent in acute non‐A, non‐B, and non‐C hepatitis patients in Hungary. 10.5% of the 264 acute non‐A, non